Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Medical Economics|February 17, 2016
Cost-effectiveness of ranibizumab in the treatment of visual impairment due to diabetic macular edemaJennifer Haig, Martin Barbeau, Alberto Ferreira
Clinicoeconomics and Outcomes Research : CEOR|May 23, 2015
Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspectiveStephane A Régnier, William Malcolm, Jennifer Haig, et al.
Drugs & Aging|October 11, 2014
Ranibizumab, verteporfin photodynamic therapy or observation for the treatment of myopic choroidal neovascularization: cost effectiveness in the UKLindsay Claxton, Bill Malcolm, Matthew Taylor, et al.
BMC Public Health|October 16, 2012
Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in CanadaMichele Kohli, Donna Lawrence, Jennifer Haig, et al.
Pharmacoeconomics|March 7, 2014
A comparative analysis of two contrasting European approaches for rewarding the value added by drugs for cancer: England versus FranceMichael Drummond, Gerard de Pouvourville, Elizabeth Jones, et al.
Biomedical Materials (Bristol, England)|June 5, 2008
Porcine bladder acellular matrix (ACM): protein expression, mechanical propertiesWalid A Farhat, Jun Chen, Jennifer Haig, et al.
Tissue Engineering. Part A|March 13, 2008
Feasibility study of a novel urinary bladder bioreactorM Chad Wallis, Herman Yeger, Lisa Cartwright, et al.
Pageof 1